Daiichi Sankyo Co Ltd 2025 IR

The report outlines the Daiichi Sankyo Group's strategic initiatives and performance for fiscal year 2024, focusing on its transition toward becoming an innovative global healthcare company by 2030. Key highlights include significant revenue growth driven by oncology products like Enhertu and Datroway, alongside substantial investments in research and development and manufacturing infrastructure. The company also details its human capital strategy, including the launch of the DS Academy, and its commitment to patient centricity. On the environmental front, Daiichi Sankyo achieved a 42.7% reduction in Scope 1 and Scope 2 CO2 emissions compared to FY2015, supported by a 79.9% renewable electricity utilization rate.

Company: Daiichi Sankyo Co Ltd

Sector: Health Care

Country: Japan

Year: 2025

Type: IR

Pages: 106

Back to company

Daiichi Sankyo Co Ltd

Daiichi Sankyo Co Ltd 2025 Value Report

Value Report

The report outlines the Daiichi Sankyo Group's strategic initiatives and performance for fiscal year 2024, focusing on its transition toward becoming an innovative global healthcare company by 2030. Key highlights include significant revenue growth driven by oncology products like Enhertu and Datroway, alongside substantial investments in research and development and manufacturing infrastructure. The company also details its human capital strategy, including the launch of the DS Academy, and its commitment to patient centricity. On the environmental front, Daiichi Sankyo achieved a 42.7% reduction in Scope 1 and Scope 2 CO2 emissions compared to FY2015, supported by a 79.9% renewable electricity utilization rate.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2025

Reporting Period

Apr 1, 2024 - Mar 31, 2025

Fiscal Year

2024

Type

Integrated Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Assurance

Assurance Provider

Assurance Standard

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Scope 3:

Energy Consumption

Renewable Energy

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Net Zero Target

Employees